retatrutide triple hormone receptor agonist weight loss Unapproved drug causes extreme side effects Media Centre | EASD

We are encouraged by these results and how they can potentially help tackle a disease that is currently without any approved therapies, Sanyal said

However, retatrutide has higher discontinuation rates and an emerging safety signal (dysesthesia) not seen with the other medications

In clinical research, participants taking the highest dose of Retatrutide lost an average of 24.2% of their body weight over 48 weeks

If youre not sure whether nutrition counseling is included in your benefits, contact your health insurance provider or, if you have employee-sponsored insurance, speak with your HR department

Im so nauseous, Im on Ozempic, she said

WHAT ARE THE POTENTIAL SIDE EFFECTS OF GLP-1 SUPPLEMENTS